The second point supporting our assertion comes from our preliminary experience in using HFNC to oxygenate infants undergoing endotracheal intubation, despite a high alveolar ventilation/functional residual lung capacity ratio and a high oxygen uptake with a consequently short desaturation time. We used HFNC in 20 infants younger than 3 months old undergoing endotracheal intubation and found that the benefit differed remarkably between those with healthy or injured lungs. Our study protocol consisted in giving 1-2 L/kg/min HFNC oxygen therapy 2 minutes before patients received sedation with fentanyl and propofol and then continuing HFNC during laryngoscopy and between attempts at intubation. If desaturation episodes less than 96% developed at any time, the mouth was gently closed to increase pharyngeal pressure, and when Sao 2 reached 100%, the procedure was resumed. If Sao 2 dropped to less than 86%, HFNC was suspended and the infant was bag ventilated. The results are shown in Table 1. We believe that despite physiologic differences between children and adults, these conflicting data underscore the need for randomized controlled trials to test the effect of HFNC before and during endotracheal intubation in patients stratified according to lung disease.The authors have disclosed that they do not have any potential conflicts of interest.